EDGAR Filing Documents for 0000950170-24-047020

Form 8-K - Current report:

SEC Accession No. 0000950170-24-047020

Filing Date

2024-04-23

Accepted

2024-04-23 17:00:12

Documents

Period of Report

2024-04-17

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	rnlx-20240417.htm iXBRL	8-K	65425
2	EX-10.1	rnlx-ex10_1.htm	EX-10.1	19702
3	EX-10.2	rnlx-ex10_2.htm	EX-10.2	62070
4	GRAPHIC	img184115036_0.jpg	GRAPHIC	12775
	Complete submission text file	0000950170-24-047020.txt		339900

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT	rnlx-20240417.xsd	EX-101.SCH	52658
18	EXTRACTED XBRL INSTANCE DOCUMENT	rnlx-20240417_htm.xml	XML	5892

Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE

Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570

Renalytix plc (Filer) CIK: 0001811115 (see all company filings)